This list is based on the watchlists of people on Stock Events who follow NSPXD. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Show more...
FAQ
What is Rebus Hldgs stock price today?▼
The current price of NSPXD is $0.1 USD — it has increased by +0.21% in the past 24 hours. Watch Rebus Hldgs stock price performance more closely on the chart.
What is Rebus Hldgs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rebus Hldgs stocks are traded under the ticker NSPXD.
What is Rebus Hldgs market cap?▼
Today Rebus Hldgs has the market capitalization of 476,000
What were Rebus Hldgs earnings last quarter?▼
NSPXD earnings for the last quarter are 0.45 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rebus Hldgs revenue for the last year?▼
Rebus Hldgs revenue for the last year amounts to 0 USD.
What is Rebus Hldgs net income for the last year?▼
NSPXD net income for the last year is 2.7M USD.
In which sector is Rebus Hldgs located?▼
Rebus Hldgs operates in the Healthcare sector.
When did Rebus Hldgs complete a stock split?▼
Rebus Hldgs has not had any recent stock splits.
Where is Rebus Hldgs headquartered?▼
Rebus Hldgs is headquartered in Westlake Village, US.